Role of transient elasticity of liver in diagnosis and prognosis of hepatic sinus obstruction syndrome induced by Panax notoginseng

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200063829

Enrollment

Unknown

Registered

2022-09-18

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic sinusoidal obstruction syndrome,HSOS

Interventions

Gold Standard:Pyrrole alkaloid related HSOS (PA-HSOS) was diagnosed according to Baltimore and Seattle standards. Patients with a clear history of taking Panax notoginseng had 3 of the following 4 ite

Index test:FibroScan test (Echoens, Paris, France).

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients admitted to Zhenjiang Third Affiliated Hospital of Jiangsu University from October 2022 to December 2024 with a history of taking soil ginseng were included.

Exclusion criteria

Exclusion criteria: 1. Patients with a body mass index (BMI)>40.

Design outcomes

Primary

Measure	Time frame
liver stiffness measurement;accuracy, specificity, sensitivity, AUC of ROC;	—

Secondary

Measure	Time frame
Liver function;	—

Countries

China

Contacts

Public ContactYouwen Tan

The Third People's Hospital of Zhenjiang

tyw915@sina.com+86 13914567088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026